Ernest Beutler Lecture and Prize Recipients
Named for the late Dr. Ernest Beutler, a past president of ASH and physician-scientist for more than 50 years, this two-part lectureship is intended to recognize major translational advances related to a single topic. Each year, ASH presents this award to two individuals: one who has enabled advances in basic science and one for achievements in clinical science or translational research.
Learn more about the Ernest Beutler Lecture and Prize.
| Year | Recipients | Information | Topic | |
|---|---|---|---|---|
| 2025 | Radek Skoda, MD | Ruben Mesa, MD | Press Release | Myeloproliferative Neoplasms: How JAK2 Became Key to Better Diagnosis, Prognosis, and Targeted Therapy |
| 2024 | Stuart Orkin, MD | John Tisdale, MD | Controlling Hemoglobin Genes and Curing the Hemoglobin Disorders | |
| 2023 | Johnny Mahlangu, MBBCh, MMed | Takehisa Kitazawa, DVM, PhD | Non-Replacement Therapy in Hemophilia Management: The Evolution of FVIII Mimetics from Basic Science to Clinical Translation | |
| 2022 | John Atkinson, MD | Peter Hillmen, MD, PhD | The Complement System and Medicine: The Good, the Bad, the Future | |
| 2021 | Margaret Shipp, MD | Stephen Ansell, MD, PhD | Releasing the brake: Checkpoint inhibition in lymphoid malignancies | |
| 2020 | Ari Melnick, MD | Courtney DiNardo, MD | Press release | Targeting the Aberrant Leukemia Epigenome |
| 2019 | Sriram Krishnaswamy, PhD | Jeffrey I. Weitz, MD | Blood Coagulation: From Molecular Mechanisms to Treatment of Thrombosis | |
| 2018 | Alan D. D’Andrea, MD | Neal S. Young, MD | Bone Marrow Failure | |
| 2017 | Luigi Naldini, MD, PhD | Marina Cavazzana, MD, PhD | Press release | Turning Foes Into Friends: Exploiting HIV to Generate Efficient and Safe Vectors to Cure Inherited and Acquired Blood Diseases |
| 2016 | Zhu Chen, MD | Hugues de Thé, MD, PhD | Acute Promyelocytic Leukemia: A Model for Precision Medicine and Cure by Targeted Therapies | |
| 2015 | Alfred Goldberg, PhD | Paul Richardson, MD | Understanding the Proteasome: From Protein Degradation to Disease Therapy | |
| 2014 | Michael DeBaun, MD, MPH | Robert P. Hebbel, MD | Sickle Cell Disease: Improved Understanding but Continued Challenges | |
| 2013 | Kenneth Kaushansky, MD | David J. Kuter, MD, DPhil | Thrombopoietin: From Molecule to Medicine | |
| 2012 | Bruce R. Blazar, MD | Carl H. June, MD | T-Cell Infusions: A New Tool for Transfusion Medicine That Has Come of Age | |
| 2011 | Brian J. Druker | Janet D. Rowley | Chronic Myeloid Leukemia (CML): A Success Story from Chromosomes to Effective Therapy | |
| 2010 | Barry S. Coller | Joel S. Bennett | From the Mechanism of Platelet Aggregation to the First Rationally Designed Antiplatelet Agent | |
| 2009 | Thomas Maniati | Yuet Wai Kan | The True Meaning of Bench to Bedside | |